Loading clinical trials...
Loading clinical trials...
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma: a Multicenter, Non-interventional, Retrospective Survey
Conditions
Locations
2
China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Tongji Hospital, Tongji Medical College of Hust
Wuhan, Hubei, China
Start Date
November 1, 2007
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
March 18, 2013
NCT07485114
NCT06391099
NCT05738694
NCT07227402
NCT06349642
NCT07300241
Lead Sponsor
Cancer Foundation, China
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions